{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:08:18Z","timestamp":1793862498347,"version":"4.6.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T00:00:00Z","timestamp":1671580800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Transcutaneous auricular vagus nerve stimulation (taVNS) has been investigated as a novel neuromodulation tool. Although taVNS is generally considered safe with only mild and transient adverse effects (AEs), those specifically caused by taVNS have not yet been investigated. This systematic review and meta-analysis on taVNS aimed to (1) systematically analyze study characteristics and AE assessment, (2) characterize and analyze possible AEs and their incidence, (3) search for predictable risk factors, (4) analyze the severity of AE, and (5) suggest an evidence-based taVNS adverse events questionnaire for safety monitoring. The articles searched were published through April 7, 2022, in Medline, Embase, Web of Science, Cochrane, and Lilacs databases. In general, we evaluated 177 studies that assessed 6322 subjects. From these, 55.37% of studies did not mention the presence or absence of any AEs; only 24.86% of the studies described that at least one adverse event occurred. In the 35 studies reporting the number of subjects with at least one adverse event, a meta-analytic approach to calculate the risk differences of developing an adverse event between active taVNS and controls was used. The meta-analytic overall adverse events incidence rate was calculated for the total number of adverse events reported on a 100,000 person-minutes-days scale. There were no differences in risk of developing an adverse event between active taVNS and controls. The incidence of AE, in general, was 12.84\/100,000 person-minutes-days of stimulation, and the most frequently reported were ear pain, headache, and tingling. Almost half of the studies did not report the presence or absence of any AEs. We attribute this to the absence of AE in those studies. There was no causal relationship between taVNS and severe adverse events. This is the first systematic review and meta-analysis of transcutaneous auricular stimulation safety. Overall, taVNS is a safe and feasible option for clinical intervention.<\/jats:p>","DOI":"10.1038\/s41598-022-25864-1","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:02:50Z","timestamp":1671616970000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":197,"title":["Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis"],"prefix":"10.1038","volume":"12","author":[{"given":"Angela Yun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Marduy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo S.","family":"de Melo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolyna","family":"Gianlorenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Jun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Fregni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,21]]},"reference":[{"key":"25864_CR1","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fnins.2018.00049","volume":"12","author":"B Bonaz","year":"2018","unstructured":"Bonaz, B., Bazin, T. & Pellissier, S. The vagus nerve at the interface of the microbiota-gut-brain axis. Front. Neurosci. 12, 49. https:\/\/doi.org\/10.3389\/fnins.2018.00049 (2018).","journal-title":"Front. Neurosci."},{"key":"25864_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/nmo.12076","volume":"25","author":"B Bonaz","year":"2013","unstructured":"Bonaz, B., Picq, C., Sinniger, V., Mayol, J. F. & Claren\u00e7on, D. Vagus nerve stimulation: From epilepsy to the cholinergic anti-inflammatory pathway. Neurogastroenterol. Motil. 25, 208\u2013221. https:\/\/doi.org\/10.1111\/nmo.12076 (2013).","journal-title":"Neurogastroenterol. Motil."},{"key":"25864_CR3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1042\/cs20210507","volume":"136","author":"E Goggins","year":"2022","unstructured":"Goggins, E., Mitani, S. & Tanaka, S. Clinical perspectives on vagus nerve stimulation: Present and future. Clin. Sci. (Lond) 136, 695\u2013709. https:\/\/doi.org\/10.1042\/cs20210507 (2022).","journal-title":"Clin. Sci. (Lond)"},{"key":"25864_CR4","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/ene.12629","volume":"22","author":"E Ben-Menachem","year":"2015","unstructured":"Ben-Menachem, E., Revesz, D., Simon, B. J. & Silberstein, S. Surgically implanted and non-invasive vagus nerve stimulation: A review of efficacy, safety and tolerability. Eur. J. Neurol. 22, 1260\u20131268. https:\/\/doi.org\/10.1111\/ene.12629 (2015).","journal-title":"Eur. J. Neurol."},{"key":"25864_CR5","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/nmo.12792","volume":"28","author":"B Bonaz","year":"2016","unstructured":"Bonaz, B. et al. Chronic vagus nerve stimulation in Crohn\u2019s disease: A 6-month follow-up pilot study. Neurogastroenterol. Motil. 28, 948\u2013953. https:\/\/doi.org\/10.1111\/nmo.12792 (2016).","journal-title":"Neurogastroenterol. Motil."},{"key":"25864_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2147\/jir.S163248","volume":"11","author":"RL Johnson","year":"2018","unstructured":"Johnson, R. L. & Wilson, C. G. A review of vagus nerve stimulation as a therapeutic intervention. J. Inflamm. Res. 11, 203\u2013213. https:\/\/doi.org\/10.2147\/jir.S163248 (2018).","journal-title":"J. Inflamm. Res."},{"key":"25864_CR7","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/j.1528-1157.1999.tb02019.x","volume":"40","author":"JJ Asconap\u00e9","year":"1999","unstructured":"Asconap\u00e9, J. J., Moore, D. D., Zipes, D. P., Hartman, L. M. & Duffell, W. H. Jr. Bradycardia and asystole with the use of vagus nerve stimulation for the treatment of epilepsy: A rare complication of intraoperative device testing. Epilepsia 40, 1452\u20131454. https:\/\/doi.org\/10.1111\/j.1528-1157.1999.tb02019.x (1999).","journal-title":"Epilepsia"},{"issue":"Suppl 1","key":"25864_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/epi.13678","volume":"58","author":"F Giordano","year":"2017","unstructured":"Giordano, F., Zicca, A., Barba, C., Guerrini, R. & Genitori, L. Vagus nerve stimulation: Surgical technique of implantation and revision and related morbidity. Epilepsia 58(Suppl 1), 85\u201390. https:\/\/doi.org\/10.1111\/epi.13678 (2017).","journal-title":"Epilepsia"},{"key":"25864_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s003810050021","volume":"16","author":"EC Ventureyra","year":"2000","unstructured":"Ventureyra, E. C. Transcutaneous vagus nerve stimulation for partial-onset seizure therapy. A new concept. Childs Nerv. Syst. 16, 101\u2013102. https:\/\/doi.org\/10.1007\/s003810050021 (2000).","journal-title":"Childs Nerv. Syst."},{"key":"25864_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2020.568051","author":"AD Farmer","year":"2021","unstructured":"Farmer, A. D. et al. International consensus based review and recommendations for minimum reporting standards in research on transcutaneous vagus nerve stimulation (version 2020). Front. Hum. Neurosci. https:\/\/doi.org\/10.3389\/fnhum.2020.568051 (2021).","journal-title":"Front. Hum. Neurosci."},{"key":"25864_CR11","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.brs.2018.08.010","volume":"11","author":"J Redgrave","year":"2018","unstructured":"Redgrave, J. et al. Safety and tolerability of Transcutaneous Vagus Nerve stimulation in humans; A systematic review. Brain Stimul. 11, 1225\u20131238. https:\/\/doi.org\/10.1016\/j.brs.2018.08.010 (2018).","journal-title":"Brain Stimul."},{"key":"25864_CR12","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.brs.2014.11.018","volume":"8","author":"E Frangos","year":"2015","unstructured":"Frangos, E., Ellrich, J. & Komisaruk, B. R. Non-invasive access to the vagus nerve central projections via electrical stimulation of the external ear: fMRI evidence in humans. Brain Stimul. 8, 624\u2013636. https:\/\/doi.org\/10.1016\/j.brs.2014.11.018 (2015).","journal-title":"Brain Stimul."},{"key":"25864_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00284","author":"JYY Yap","year":"2020","unstructured":"Yap, J. Y. Y. et al. Critical review of transcutaneous vagus nerve stimulation: Challenges for translation to clinical practice. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2020.00284 (2020).","journal-title":"Front. Neurosci."},{"key":"25864_CR14","doi-asserted-by":"publisher","DOI":"10.3791\/58984","author":"BW Badran","year":"2019","unstructured":"Badran, B. W. et al. Laboratory administration of transcutaneous auricular vagus nerve stimulation (taVNS): Technique, targeting, and considerations. J. Vis. Exp. https:\/\/doi.org\/10.3791\/58984 (2019).","journal-title":"J. Vis. Exp."},{"key":"25864_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41539-020-0070-0","volume":"5","author":"F Llanos","year":"2020","unstructured":"Llanos, F. et al. Non-invasive peripheral nerve stimulation selectively enhances speech category learning in adults. NPJ Sci. Learn. 5, 12. https:\/\/doi.org\/10.1038\/s41539-020-0070-0 (2020).","journal-title":"NPJ Sci. Learn."},{"key":"25864_CR16","doi-asserted-by":"publisher","first-page":"e115","DOI":"10.1111\/j.1528-1167.2012.03492.x","volume":"53","author":"H Stefan","year":"2012","unstructured":"Stefan, H. et al. Transcutaneous vagus nerve stimulation (t-VNS) in pharmacoresistant epilepsies: A proof of concept trial. Epilepsia 53, e115-118. https:\/\/doi.org\/10.1111\/j.1528-1167.2012.03492.x (2012).","journal-title":"Epilepsia"},{"key":"25864_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.664740","author":"N Verma","year":"2021","unstructured":"Verma, N. et al. Auricular vagus neuromodulation\u2014A systematic review on quality of evidence and clinical effects. Front. Neurosci. https:\/\/doi.org\/10.3389\/fnins.2021.664740 (2021).","journal-title":"Front. Neurosci."},{"key":"25864_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/17434440.2022.2020095","volume":"19","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Transcutaneous auricular vagus nerve stimulators: A review of past, present, and future devices. Expert Rev. Med. Devices 19, 43\u201361. https:\/\/doi.org\/10.1080\/17434440.2022.2020095 (2022).","journal-title":"Expert Rev. Med. Devices"},{"key":"25864_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page, M. J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 372, n71. https:\/\/doi.org\/10.1136\/bmj.n71 (2021).","journal-title":"BMJ"},{"key":"25864_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"JPT Higgins","year":"2019","unstructured":"Higgins, J. P. T. et al. Cochrane Handbook for Systematic Reviews of Interventions (Wiley, 2019)."},{"key":"25864_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","volume":"22","author":"S Balduzzi","year":"2019","unstructured":"Balduzzi, S., R\u00fccker, G. & Schwarzer, G. How to perform a meta-analysis with R: A practical tutorial. Evid. Based Ment. Health 22, 153\u2013160. https:\/\/doi.org\/10.1136\/ebmental-2019-300117 (2019).","journal-title":"Evid. Based Ment. Health"},{"key":"25864_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1751-0473-3-17","volume":"3","author":"Z Bursac","year":"2008","unstructured":"Bursac, Z., Gauss, C. H., Williams, D. K. & Hosmer, D. W. Purposeful selection of variables in logistic regression. Source Code Biol. Med. 3, 17. https:\/\/doi.org\/10.1186\/1751-0473-3-17 (2008).","journal-title":"Source Code Biol. Med."},{"key":"25864_CR23","unstructured":"RStudioTeam. RStudio: Integrated Development Environment for R. RStudio, PBC, Boston, MA. (2022. http:\/\/www.rstudio.com\/)."},{"key":"25864_CR24","unstructured":"CTEP. Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP, <https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm> (2022. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm)."},{"key":"25864_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12982-015-0037-4","volume":"12","author":"KM Fedak","year":"2015","unstructured":"Fedak, K. M., Bernal, A., Capshaw, Z. A. & Gross, S. Applying the Bradford Hill criteria in the 21st century: How data integration has changed causal inference in molecular epidemiology. Emerg. Themes Epidemiol. 12, 14. https:\/\/doi.org\/10.1186\/s12982-015-0037-4 (2015).","journal-title":"Emerg. Themes Epidemiol."},{"key":"25864_CR26","doi-asserted-by":"publisher","first-page":"l4898","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JAC Sterne","year":"2019","unstructured":"Sterne, J. A. C. et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 366, l4898. https:\/\/doi.org\/10.1136\/bmj.l4898 (2019).","journal-title":"BMJ"},{"key":"25864_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3109\/00016489.2012.750736","volume":"133","author":"J Lehtim\u00e4ki","year":"2013","unstructured":"Lehtim\u00e4ki, J. et al. Transcutaneous vagus nerve stimulation in tinnitus: A pilot study. Acta Otolaryngol. 133, 378\u2013382. https:\/\/doi.org\/10.3109\/00016489.2012.750736 (2013).","journal-title":"Acta Otolaryngol."},{"key":"25864_CR28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00702-012-0908-6","volume":"120","author":"E Hein","year":"2013","unstructured":"Hein, E. et al. Auricular transcutaneous electrical nerve stimulation in depressed patients: A randomized controlled pilot study. J. Neural Transm. (Vienna) 120, 821\u2013827. https:\/\/doi.org\/10.1007\/s00702-012-0908-6 (2013).","journal-title":"J. Neural Transm. (Vienna)"},{"key":"25864_CR29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s10194-015-0543-3","volume":"16","author":"A Straube","year":"2015","unstructured":"Straube, A., Ellrich, J., Eren, O., Blum, B. & Ruscheweyh, R. Treatment of chronic migraine with transcutaneous stimulation of the auricular branch of the vagal nerve (auricular t-VNS): A randomized, monocentric clinical trial. J. Headache Pain 16, 543. https:\/\/doi.org\/10.1186\/s10194-015-0543-3 (2015).","journal-title":"J. Headache Pain"},{"key":"25864_CR30","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1016\/j.neurobiolaging.2015.02.023","volume":"36","author":"HI Jacobs","year":"2015","unstructured":"Jacobs, H. I., Riphagen, J. M., Razat, C. M., Wiese, S. & Sack, A. T. Transcutaneous vagus nerve stimulation boosts associative memory in older individuals. Neurobiol. Aging 36, 1860\u20131867. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.02.023 (2015).","journal-title":"Neurobiol. Aging"},{"key":"25864_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fpsyt.2012.00070","volume":"3","author":"PM Kreuzer","year":"2012","unstructured":"Kreuzer, P. M. et al. Transcutaneous vagus nerve stimulation: Retrospective assessment of cardiac safety in a pilot study. Front. Psychiatry 3, 70. https:\/\/doi.org\/10.3389\/fpsyt.2012.00070 (2012).","journal-title":"Front. Psychiatry"},{"key":"25864_CR32","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00406-015-0618-9","volume":"265","author":"A Hasan","year":"2015","unstructured":"Hasan, A. et al. Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: A bicentric randomized controlled pilot study. Eur. Arch. Psychiatry Clin. Neurosci. 265, 589\u2013600. https:\/\/doi.org\/10.1007\/s00406-015-0618-9 (2015).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"25864_CR33","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.brs.2015.11.003","volume":"9","author":"S Bauer","year":"2016","unstructured":"Bauer, S. et al. Transcutaneous vagus nerve stimulation (tVNS) for treatment of drug-resistant epilepsy: a randomized, double-blind clinical trial (cMPsE02). Brain Stimul. 9, 356\u2013363. https:\/\/doi.org\/10.1016\/j.brs.2015.11.003 (2016).","journal-title":"Brain Stimul."},{"key":"25864_CR34","doi-asserted-by":"publisher","first-page":"e023582","DOI":"10.1161\/jaha.121.023582","volume":"11","author":"S Stavrakis","year":"2022","unstructured":"Stavrakis, S. et al. Neuromodulation of inflammation to treat heart failure with preserved ejection fraction: A pilot randomized clinical trial. J. Am. Heart Assoc. 11, e023582. https:\/\/doi.org\/10.1161\/jaha.121.023582 (2022).","journal-title":"J. Am. Heart Assoc."},{"key":"25864_CR35","doi-asserted-by":"publisher","first-page":"e024537","DOI":"10.1136\/bmjopen-2018-024537","volume":"9","author":"R Phillips","year":"2019","unstructured":"Phillips, R., Hazell, L., Sauzet, O. & Cornelius, V. Analysis and reporting of adverse events in randomised controlled trials: A review. BMJ Open 9, e024537. https:\/\/doi.org\/10.1136\/bmjopen-2018-024537 (2019).","journal-title":"BMJ Open"},{"key":"25864_CR36","doi-asserted-by":"publisher","first-page":"e1002127","DOI":"10.1371\/journal.pmed.1002127","volume":"13","author":"S Golder","year":"2016","unstructured":"Golder, S., Loke, Y. K., Wright, K. & Norman, G. Reporting of adverse events in published and unpublished studies of health care interventions: A systematic review. PLOS Med. 13, e1002127. https:\/\/doi.org\/10.1371\/journal.pmed.1002127 (2016).","journal-title":"PLOS Med."},{"key":"25864_CR37","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1212\/wnl.0000000000002918","volume":"87","author":"SD Silberstein","year":"2016","unstructured":"Silberstein, S. D. et al. Chronic migraine headache prevention with noninvasive vagus nerve stimulation: The EVENT study. Neurology 87, 529\u2013538. https:\/\/doi.org\/10.1212\/wnl.0000000000002918 (2016).","journal-title":"Neurology"},{"key":"25864_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/head.12650","volume":"56","author":"H Yuan","year":"2016","unstructured":"Yuan, H. & Silberstein, S. D. Vagus Nerve and vagus nerve stimulation, a comprehensive review: Part II. Headache 56, 259\u2013266. https:\/\/doi.org\/10.1111\/head.12650 (2016).","journal-title":"Headache"},{"key":"25864_CR39","doi-asserted-by":"publisher","first-page":"7830919","DOI":"10.1155\/2017\/7830919","volume":"2017","author":"P Bermejo","year":"2017","unstructured":"Bermejo, P. et al. Innervation of the human cavum conchae and auditory canal: Anatomical basis for transcutaneous auricular nerve stimulation. Biomed. Res. Int. 2017, 7830919. https:\/\/doi.org\/10.1155\/2017\/7830919 (2017).","journal-title":"Biomed. Res. Int."},{"key":"25864_CR40","doi-asserted-by":"crossref","unstructured":"Tyler, W., Wyckoff, S., Hearn, T. & Hool, N. The Safety and Efficacy of Transdermal Auricular Vagal Nerve Stimulation Earbud Electrodes for Modulating Autonomic Arousal, Attention, Sensory Gating, and Cortical Brain Plasticity in Humans. (2019).","DOI":"10.1101\/732529"},{"key":"25864_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/ner.12541","volume":"20","author":"N Yakunina","year":"2017","unstructured":"Yakunina, N., Kim, S. S. & Nam, E. C. Optimization of transcutaneous vagus nerve stimulation using functional MRI. Neuromodulation 20, 290\u2013300. https:\/\/doi.org\/10.1111\/ner.12541 (2017).","journal-title":"Neuromodulation"},{"key":"25864_CR42","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1038\/sj.npp.1301082","volume":"31","author":"CB Nemeroff","year":"2006","unstructured":"Nemeroff, C. B. et al. VNS therapy in treatment-resistant depression: Clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology 31, 1345\u20131355. https:\/\/doi.org\/10.1038\/sj.npp.1301082 (2006).","journal-title":"Neuropsychopharmacology"},{"key":"25864_CR43","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.clinph.2018.05.026","volume":"129","author":"M Keute","year":"2018","unstructured":"Keute, M., Ruhnau, P., Heinze, H. J. & Zaehle, T. Behavioral and electrophysiological evidence for GABAergic modulation through transcutaneous vagus nerve stimulation. Clin. Neurophysiol. 129, 1789\u20131795. https:\/\/doi.org\/10.1016\/j.clinph.2018.05.026 (2018).","journal-title":"Clin. Neurophysiol."},{"key":"25864_CR44","doi-asserted-by":"publisher","first-page":"e0247653","DOI":"10.1371\/journal.pone.0247653","volume":"16","author":"JA Muthulingam","year":"2021","unstructured":"Muthulingam, J. A. et al. Cervical transcutaneous vagal neuromodulation in chronic pancreatitis patients with chronic pain: A randomised sham-controlled clinical trial. PLoS ONE 16, e0247653. https:\/\/doi.org\/10.1371\/journal.pone.0247653 (2021).","journal-title":"PLoS ONE"},{"key":"25864_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00702-014-1299-7","volume":"122","author":"F Capone","year":"2015","unstructured":"Capone, F. et al. The effect of transcutaneous vagus nerve stimulation on cortical excitability. J. Neural. Transm. (Vienna) 122, 679\u2013685. https:\/\/doi.org\/10.1007\/s00702-014-1299-7 (2015).","journal-title":"J. Neural. Transm. (Vienna)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25864-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25864-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:13:06Z","timestamp":1671621186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-25864-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,21]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["25864"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-25864-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,21]]},"assertion":[{"value":"19 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.Y.K. has no conflicts of interest to declare. C.K.K., H.C. and J.S. are directly associated with Neurive Co, a company developing neuromodulation technologies, such as taVNS, to treat common brain diseases. A.C.G. is supported by the Federal University S\u00e3o Carlos and is a consultant for Neurive. P.S.dM. and A.M. are consultants for Neurive. F.F. is supported by NIH grants and is a consultant for Neurive.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22055"}}